Ribon Therapeutics
is a Massachusetts-based biopharmaceutical company that researches and develops novel small molecule therapeutics for the treatment of cancer... Read moreRibon Therapeutics
is a Massachusetts-based biopharmaceutical company that researches and develops novel small molecule therapeutics for the treatment of cancer... Read more
President & CEO
Prakash Raman
News
Aug 05, 2024
PharmaLive
Ribon Therapeutics: Big Pharma-backed Ribon Therapeutics shuts down business operations
Aug 02, 2024
Endpoints News
Ribon Therapeutics: PARP biotech backed by more than five pharmas closes after nine years
Dec 22, 2023
Pharamceutical Technology
Ribon Therapeutics: Atamparib by Ribon Therapeutics for Breast Cancer: Likelihood of Approval
Jul 31, 2023
The Business Journals: Boston
Ribon Therapeutics: Cambridge biotech Ribon cuts employees, halts preclinical work
Jul 28, 2023
Endpoints News
Ribon Therapeutics: Ribon Therapeutics rids preclinical work, trims staff to focus on two clinical PARP inhibitors
Mar 08, 2023
Acrofan
Ribon Therapeutics: Ribon Therapeutics Doses First Patient in Phase 1 Clinical Study with RBN-3143 in Patients with Moderate-to-Severe Atopic Dermatitis
Jan 30, 2023
Citybizlist
Ribon Therapeutics: Ribon Therapeutics Announces $25 Million Equity Investment from Pfizer
Jan 30, 2023
Endpoints News
Ribon Therapeutics: Pfizer invests in Ribon Therapeutics; Argenx gets PDUFA date extension
Dec 22, 2022
SEC
Ribon Therapeutics: RIBON THERAPEUTICS has Received $25M in Equity Funding
Nov 29, 2022
Citybizlist
Ribon Therapeutics: Ribon Therapeutics Announces Acquisition of Pre-Clinical CD38 Program by Boehringer Ingelheim
Ribon Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10